亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study.

弗雷克斯 队列 骨矿物 回顾性队列研究 股骨颈 双膦酸盐 前瞻性队列研究 优势比 置信区间 骨密度 入射(几何) 共病 骨质疏松性骨折
作者
Shau Huai Fu,Chen-Yu Wang,Chih Chien Hung,Chia Che Lee,Rong-Sen Yang,Chuan Ching Huang,Chui Jia Farn,Wei-Hsin Lin,Ho Min Chen,Fei-Yuan Hsiao,Jou-Wei Lin,C.‐Y. Li
出处
期刊:Journal of Internal Medicine [Wiley]
卷期号:290 (6): 1194-1205 被引量:5
标识
DOI:10.1111/joim.13354
摘要

Background To compare the risks of major osteoporotic, vertebral, and non-vertebral fractures between patients who discontinued anti-osteoporosis medications. Methods We conducted a comparative effectiveness study with a nationwide population-based cohort study design. Patients aged ≥50 years admitted between 2012 and 2015 for incident hip fractures and receiving denosumab or bisphosphonates with sufficient compliance for at least one year were included. Patients were categorized into persistent or non-persistent denosumab or bisphosphonates users based on their subsequent use pattern. The main outcomes were subsequent hospitalizations for a major osteoporotic, vertebral or non-vertebral fracture. Multivariate, time-varying Cox proportional hazards model was used to evaluate the risk of major outcomes. Results Compared with persistent denosumab users, non-persistent denosumab users had a significantly higher risk of major osteoporotic fractures (Hazard ratio (HR) = 1.60; 95% confidence interval (CI), 1.20 to 2.14),vertebral fractures (HR = 2.18; 95% CI, 1.46 to 3.24) and death (HR = 3.57; 95%CI, 2.63-4.84). However, the increased risk of fracture was not found in both persistent and non-persistent bisphosphonates users. Noteworthy, the increased risk of vertebral fractures in non-persistent denosumab users was more pronounced within one-year post discontinuation (HR = 2.90, 95% CI, 1.77 to 4.74) and among patients who discontinued from 2-year denosumab therapy (HR = 3.58; 95% CI, 1.74 to7.40). Discussion Discontinuation of denosumab resulted in an increased risk of major osteoporotic fractures, especially vertebral fractures. The increased risk tends to reveal within one-year post discontinuation and be greater after a longer treatment duration. Notably, only fracture with hospitalization was identified as our research outcome, the real risk of osteoporotic fracture post discontinuation is believed to be higher, especially for vertebral fracture. This article is protected by copyright. All rights reserved.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
执着忆寒完成签到,获得积分10
刚刚
369ninja的应助被科研通管家采纳,获得10
2秒前
灵巧绿海发布了新的文献求助10
5秒前
11秒前
17秒前
atrados发布了新的文献求助30
18秒前
35秒前
干净的醉蝶完成签到,获得积分10
40秒前
正直的晓槐完成签到,获得积分10
44秒前
程生完成签到,获得积分10
45秒前
fpy完成签到,获得积分10
52秒前
54秒前
英姑的应助被面面面面包采纳,获得10
1分钟前
1分钟前
1分钟前
年轻凌丝完成签到,获得积分10
1分钟前
suuuye发布了新的文献求助10
1分钟前
wx完成签到,获得积分10
1分钟前
乐陶完成签到 ,获得积分10
1分钟前
1分钟前
所所的应助被atrados采纳,获得10
1分钟前
合适书兰完成签到,获得积分10
1分钟前
矢思然完成签到,获得积分10
1分钟前
受不了12345完成签到,获得积分10
1分钟前
www发布了新的文献求助20
1分钟前
1分钟前
1分钟前
1分钟前
SimonShaw发布了新的文献求助10
1分钟前
www发布了新的文献求助10
1分钟前
Jun完成签到,获得积分10
1分钟前
SimonShaw完成签到,获得积分10
1分钟前
hdrizen完成签到,获得积分10
1分钟前
之桃完成签到,获得积分10
1分钟前
www完成签到,获得积分10
1分钟前
2分钟前
彭于晏的应助被李诗语采纳,获得10
2分钟前
眯眯眼的板凳完成签到,获得积分10
2分钟前
高兴之柔完成签到,获得积分10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179873
求助须知:如何正确求助?哪些是违规求助? 9570055
关于积分的说明 21808206
捐赠科研通 7775540
什么是DOI,文献DOI怎么找? 3433157
关于科研通互助平台的介绍 2557278
邀请新用户注册赠送积分活动 2478846